International Congress London 2016

Saturday, 03.09.2016
Sunday, 04.09.2016
Monday, 05.09.2016
Tuesday, 06.09.2016
Wednesday, 07.09.2016

 

Sponsored symposia:

Industry Evening Mini Symposium at ERS 2016: “Challenges in the management of non-CF bronchiectasis”

Citations should be made in the following way: Authors. Title. Eur Respir J 2016; 48: Suppl. 60, abstract number.


IPF treatment II

Oral Presentation
Chairs: Luca Richeldi (Southampton, United Kingdom), Ulrich Costabel (ESSEN, Germany)
LATE-BREAKING ABSTRACT: Significant improvement in refractory chronic cough with inhaled PA101 in patients with idiopathic pulmonary fibrosis: Results from phase 2 trial
Ahmet Tutuncu (San Diego, United States of America), Surinder Birring, Marlies Wijsenbeek, Sanjay Agrawal, Ahmet Tutuncu, Alyn Morice
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
No effect of baseline diffusing capacity of lung for carbon monoxide on benefit of nintedanib
Toby Maher (St. Albans, Hertfordshire, United Kingdom), Toby Maher, Kevin R. Flaherty, Yoshikazu Inoue, Luca Richeldi, Moisés Selman, Wibke Stansen, Susanne Stowasser, Athol Wells
Congress or journal article abstractSlide presentationE-poster
Congress or journal article abstractSlide presentationE-poster
Long-term treatment with nintedanib in patients with IPF: An update from INPULSIS®-ON
Bruno Crestani (Paris, France), Bruno Crestani, Manuel Quaresma, Mitchell Kaye, Wibke Stansen, Susanne Stowasser, Michael Kreuter
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Clinical experience with nintedanib for IPF in 3 UK tertiary referral centres
Hannah Toellner (Burntisland, United Kingdom), Hannah Toellner, W. Beswick, M.G. Crooks, C. Donaldson, I. Forrest, S.P. Hart, C. Leonard, M. Major, A.J. Simpson, N. Chaudhuri
Congress or journal article abstractSlide presentationE-poster
Congress or journal article abstractSlide presentationE-poster
Effect of baseline statin use on benefit of nintedanib
Michael Kreuter (Heidelberg, Germany), Michael Kreuter, Ulrich Costabel, Luca Richeldi, Vincent Cottin, Daniel Wachtlin, Susanne Stowasser, Martin Kolb
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Relationship between nintedanib exposure and adverse events in patients with idiopathic pulmonary fibrosis
Ulrike Schmid (Biberach an der Riss, Germany), Ulrike Schmid, Benjamin Weber, Claudia Dallinger, Luca Richeldi, Christoph Hallmann, Ganesh Raghu, Matthias Freiwald
Congress or journal article abstract
Congress or journal article abstract
Predicting life expectancy for pirfenidone and best supportive care (BSC) in idiopathic pulmonary fibrosis (IPF)
Mark Fisher (St Albans, United Kingdom), Mark Fisher, Toby M. Maher, Steven D. Nathan, Christian Hill, Jade Marshall, Fred Dejonckheere, Per-Olof Thuresson, Nitya Mathew
Congress or journal article abstract
Congress or journal article abstract
Predictors of response to pirfenidone treatment in patients with idiopathic pulmonary fibrosis (IPF)
Elisabetta Balestro (Padova, Italy), Elisabetta Balestro, Graziella Turato, Davide Biondini, Sofia Pavanello, Alessia Fraccaro, Chiara Rigobello, Erica Bazzan, Manuela Campisi, Simonetta Baraldo, Manuel Cosio, Marina Saetta, Paolo Spagnolo
Congress or journal article abstractSlide presentation
Congress or journal article abstractSlide presentation